中华生殖与避孕杂志2023年2月第43卷第2期Chin J Reprod Contracep.February2023,Vd.43.No.2·113生育力保存专栏淋巴瘤患者生育力保存临床实践中国专家共识中国医师协会生殖医学专业委员会中国临床肿瘤学会淋巴瘤专家委员会中国医疗保健国际交流促进会生殖医学分会中国抗癌协会小儿肿瘤专业委员会道信作者：严杰，Email:yanjiebjmu(@jmu.edu.cn;段彦龙，Email:duanyanlong@hotmail.com;宋玉琴，Email::songyuqine622@163.com;乔杰，Email:jie.qiao@263.net【摘要】近年来随着淋巴瘤患者治疗后生存率上升，越来越多的淋巴瘤存活者面临治愈后所带来的生育力下降问题。为保存淋巴瘤患者生育力，提升患者生存质量，根据现有的科学研究及临床实践，结合最新指南和专家意见制定本共识，涵盖淋巴瘤疾病对生育力的影响、患者生育力保存方案的选择等内容，为血液科及生殖医学专科医生提供淋巴瘤患者生育力保存临床指导策略，以更有效地解决淋巴瘤患者（包括未成年患者）的生殖健康需求。【关键词】生育力保存：淋巴瘤；早发性卵巢功能不全：专家共识基金项目：国家重点研发计划(2022YFC2703000、2022YF℃2702502)Chinese expert consensus on clinical practice of fertility preservation in lymphoma patientsChinese Association of Reproductive Medicine,Union for China Lymphoma Investigator at Chinese Society ofClinical Oncology,Reproductive Medicine Branch of China International Exchange and PromotiveAssociation for Medical and Health Care,Children's Cancer Group,Chinese Anti-Cancer AssociationCorresponding authors:Yan lie,Emaik yanjiebjmu@bjmu.edu.cn;Duan Yanlong,Email:duanyanlong@hotmailcom;Song Yugin,Email:songyugin622@163.com;Qiao Jie,Email:jie.qiao@263.netAbstract In recent years,as the survival rate of lymphoma patients has increased,moreand more lymphoma survivors are facing fertility problems caused by lymphoma treatment.In orderto preserve the fertility of lymphoma patients and improve the quality of life of patients postrecovery,this consensus is formulated based on current literature and clinical practice,referring tothe latest guidelines and expert advises.This consensus includes the impact of lymphoma on fertility,the selection of fertility preservation options for lymphoma patients,etc.It provides hematologicaland reproductive professionals with the optimal clinical guideline and strategy regarding fertilitypreservation options for lymphoma patients,so as to address the demand for reproductive health oflymphoma patients (including minors)more effectively.Key words Fertility preservation;Lymphoma;Premature ovarian insufficiency;ExpertconsensusFund program:National Key Research and Development Program of China (2022YFC2703000,2022YFC2702502]淋巴瘤是起源于淋巴结或结外淋巴组织的血液恶性肿瘤中占第12位[四，在儿童及青少年时期的恶系统恶性肿瘤，我国淋巴海发病率为556/10万四，在性肿海中占第3位[)，呈逐年增多的趋势。淋巴海D01:10.3760/cma.j.cm101441-20221222-00585收稿日期2022-12-23本文编辑王李艳引用本文：中国医师协会生殖医学专业委员会，中国临床肿瘤学会淋巴瘤专家委员会，中国医疗保健国际交流促进会生殖医学分会，等.淋巴瘤患者生有力保存临床实践中国专家共识中华生殖与避孕杂志，2023,43(2h113-122.D0L:10.3760/emaj.cnl01441-20221222-00585.
